Pingdingshan, China

Dongxu Yi

This inventor holds 1 USPTO granted patent. Top assignee: Henan Genuine Biotech Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongxu Yi. Retrieved from https://idiyas.com/inventor/dongxu-yi-h3b9z0tu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dongxu Yi

Introduction

Dongxu Yi is a notable inventor based in Pingdingshan, China. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compounds. His work focuses on innovative solutions for treating serious health conditions.

Latest Patents

Dongxu Yi holds a patent for a compound titled "2-(2,4,5-substituted phenylamino) pyrimidine derivative and crystalline form B thereof." This pyrimidine derivative is particularly useful for treating non-small cell lung cancer. The chemical formula associated with this invention demonstrates its potential in the medical field, showcasing Yi's commitment to advancing healthcare solutions. He has 1 patent to his name.

Career Highlights

Dongxu Yi is affiliated with Henan Genuine Biotech Co., Ltd., where he continues to innovate and develop new therapeutic agents. His role in the company allows him to collaborate with other talented professionals in the biotechnology sector.

Collaborations

Some of his notable coworkers include Junbiao Chang and Jinfa Du. Their collective expertise contributes to the advancement of research and development within their organization.

Conclusion

Dongxu Yi's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the area of cancer treatment, highlight the importance of research and development in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…